Nikos G. Gavalas

National and Kapodistrian University of Athens — Greece

Medicine · Health Sciences

15h-index1.1kcitations34works3.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(6), melanin and skin pigmentation(5), Angiogenesis and VEGF in Cancer(4), Adrenal Hormones and Disorders(4), T-cell and B-cell Immunology(3)

Publications34 total

Editorial: Current trends and future prospects in the use of immunotherapy in ovarian cancer
Frontiers in Oncology·2025Open Access
Intravesical Administration of Durvalumab for High-risk Non–muscle-invasive Bladder Cancer: A Phase 2 Study by the Hellenic GU Cancer Group
European Urology·2025· 7 cited
Optical fiber sensors in agricultural applications
2022· 4 cited
ERCC1 19007 Polymorphism in Greek Patients with Advanced Urothelial Cancer Treated with Platinum-Based Chemotherapy: Effect of the Changing Treatment Paradigm: A Cohort Study by the Hellenic GU Cancer Group
Current Oncology·2021· 1 citedOpen Access
Correction: Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer
PLoS ONE·2021· 1 citedOpen Access
Optical Fibre Humidity Sensor for Accessing the Wetting Condition of Oak Barrels
2021
Erratum
Oncology Research and Treatment·2018
Meetings and Conferences
Oncology Research and Treatment·2018
Aktuelle News vom ASCO-GI 2018
Oncology Research and Treatment·2018Open Access
Physicochemical Properties of Magnetic Nanoparticles: Implications for Biomedical Applications In Vitro and In Vivo
Oncology Research and Treatment·2018· 50 cited
Society Bulletins
Oncology Research and Treatment·2018Open Access
GD3 mediated immune response via vascular endothelial growth factor in ovarian cancer
Translational Cancer Research·2016Open Access
The Development of an Angiogenic Protein “Signature” in Ovarian Cancer Ascites as a Tool for Biologic and Prognostic Profiling
PLoS ONE·2016· 27 citedOpen Access
GD3 mediated immune response via vascular endothelial growth factor in ovarian cancer
Translational Cancer Research·2016
Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer
PLoS ONE·2015· 43 citedOpen Access
Angio-Inhibitors in Ovarian Cancer
Journal of Cancer Science & Therapy·2014· 2 citedOpen Access
Angiogenesis-Related Pathways in the Pathogenesis of Ovarian Cancer
International Journal of Molecular Sciences·2013· 132 citedOpen Access
Anti-tumor immune response in ovarian cancer: clinical implications, prognostic significance and potential for novel treatment strategies
Oncology Reviews·2011Open Access
Anti-tumor immune response in ovarian cancer: clinical implications, prognostic significance and potential for novel treatment strategies
Oncology Reviews·2011
VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals <i>via</i> VEGF receptor Type 2
International Journal of Cancer·2011· 163 cited
page 1 of 2Next →

Frequent Co-authors

Meletios Α. Dimopoulos(10), E. Helen Kemp(9), Anthony P. Weetman(9), Aristotelis Bamias(9), Philip F. Watson(7), David J. Gawkrodger(5), Anna A. Belanova(5), Yuriy M. Makarenko(5), Mariya M. Belousova(5), А. В. Солдатов(5), Peter V. Zolotukhin(5), Aristotle Bamias(4), Kai Krohn(4), Edward M. Brown(4), Samia Akhtar(4), Jinyan Jiang(4), Xiangyong Liu(4), Kyoungjune Pak(4), Seong‐Jang Kim(4), Samuel Chang(4)